Tuberculous pericarditis with and without HIV

[1]  R. Wilkinson,et al.  HIV-1 infection alters CD4+ memory T-cell phenotype at the site of disease in extrapulmonary tuberculosis , 2011, European journal of immunology.

[2]  MassimoImazio,et al.  Risk of Constrictive Pericarditis After Acute Pericarditis , 2011 .

[3]  Anthony D Harries,et al.  Reducing tuberculosis-associated early mortality in antiretroviral treatment programmes in sub-Saharan Africa. , 2011, AIDS.

[4]  R. Wilkinson,et al.  Clinical management of tuberculosis and HIV-1 co-infection , 2010, European Respiratory Journal.

[5]  Alimuddin Zumla,et al.  Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice , 2010, The Lancet.

[6]  W. El-Sadr,et al.  Timing of initiation of antiretroviral drugs during tuberculosis therapy. , 2010, The New England journal of medicine.

[7]  B. Mayosi,et al.  Cardiac manifestations of HIV infection: an African perspective , 2009, Nature Clinical Practice Cardiovascular Medicine.

[8]  C. Wiysonge,et al.  HIV Infection Is Associated with a Lower Incidence of Constriction in Presumed Tuberculous Pericarditis: A Prospective Observational Study , 2008, PloS one.

[9]  B. Mayosi,et al.  A modern approach to tuberculous pericarditis. , 2007, Progress in cardiovascular diseases.

[10]  M. Merx,et al.  Sepsis and the heart. , 2007, Circulation.

[11]  M. Tikly,et al.  Purulent pericarditis due to co-infection with Streptococcus pneumoniae and Mycobacterium tuberculosis in a patient with features of advanced HIV infection , 2007, BMC infectious diseases.

[12]  H. Reuter,et al.  Diagnosing tuberculous pericarditis. , 2006, QJM : monthly journal of the Association of Physicians.

[13]  Y. Enç,et al.  Chronic constrictive tuberculous pericarditis: risk factors and outcome of pericardiectomy. , 2006, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[14]  H. Reuter,et al.  Characterization of the immunological features of tuberculous pericardial effusions in HIV positive and HIV negative patients in contrast with non-tuberculous effusions. , 2006, Tuberculosis.

[15]  H. Reuter,et al.  The role of histopathology in establishing the diagnosis of tuberculous pericardial effusions in the presence of HIV , 2006, Histopathology.

[16]  K. Sliwa,et al.  Clinical characteristics and initial management of patients with tuberculous pericarditis in the HIV era: the Investigation of the Management of Pericarditis in Africa (IMPI Africa) registry , 2006, BMC infectious diseases.

[17]  B. Mayosi,et al.  Tuberculous Pericarditis , 2005, Circulation.

[18]  M. Ntsekhe,et al.  Impact of Human Immunodeficiency Virus Infection on Cardiovascular Disease in Africa , 2005, Circulation.

[19]  K. Teraoka,et al.  Delayed contrast enhancement in a patient with perimyocarditis on contrast-enhanced cardiac MRI: case report , 2005, The International Journal of Cardiovascular Imaging.

[20]  H. Reuter,et al.  Epidemiology of pericardial effusions at a large academic hospital in South Africa , 2005, Epidemiology and Infection.

[21]  Raimund Erbel,et al.  Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. , 2004, European heart journal.

[22]  E. W. Hancock,et al.  A clearer view of effusive-constrictive pericarditis. , 2004, The New England journal of medicine.

[23]  C. Wiysonge,et al.  Adjuvant corticosteroids for tuberculous pericarditis: promising, but not proven. , 2003, QJM : monthly journal of the Association of Physicians.

[24]  T. Self,et al.  Update on Rifampin and Rifabutin Drug Interactions , 2003, The American journal of the medical sciences.

[25]  S. Siziya,et al.  Double blind randomised placebo controlled trial of adjunctive prednisolone in the treatment of effusive tuberculous pericarditis in HIV seropositive patients , 2000, Heart.

[26]  D. Spodick,et al.  Constrictive pericarditis: clinical and pathophysiologic characteristics. , 1999, American heart journal.

[27]  A. Harries,et al.  Tuberculous pericardial effusion: a prospective clinical study in a low-resource setting--Blantyre, Malawi. , 1997, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[28]  L. Reller,et al.  Tuberculous pericarditis in Tanzanian patients with and without HIV infection. , 1994, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[29]  A. Pozniak,et al.  Tuberculous pericardial effusion associated with HIV infection: a sign of disseminated disease. , 1994, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[30]  M. Diomande,et al.  The mortality and pathology of HIV infection in a West African city , 1993, AIDS.

[31]  R. Shafer,et al.  Extrapulmonary Tuberculosis in Patients with Human Immunodeficiency Virus Infection , 1991, Medicine.

[32]  A. Dannenberg.  Delayed-type hypersensitivity and cell-mediated immunity in the pathogenesis of tuberculosis. , 1991, Immunology today.

[33]  K. Ramaiya,et al.  Pericardial disease and human immunodeficiency virus in Dar es Salaam, Tanzania , 1990, The Lancet.

[34]  D. Girling,et al.  CONTROLLED CLINICAL TRIAL OF COMPLETE OPEN SURGICAL DRAINAGE AND OF PREDNISOLONE IN TREATMENT OF TUBERCULOUS PERICARDIAL EFFUSION IN TRANSKEI , 1988, The Lancet.

[35]  D. Girling,et al.  CONTROLLED TRIAL OF PREDNISOLONE AS ADJUVANT IN TREATMENT OF TUBERCULOUS CONSTRICTIVE PERICARDITIS IN TRANSKEI , 1987, The Lancet.

[36]  J. Strang.  Tuberculous pericarditis in transkei , 1984, Clinical cardiology.

[37]  B. Maisch,et al.  Immune reactions in tuberculous and chronic constrictive pericarditis. Clinical data and diagnostic significance of antimyocardial antibodies. , 1982, The American journal of cardiology.

[38]  E. W. Hancock,et al.  Subacute Effusive‐Constrictive Pericarditis , 1971, Circulation.

[39]  S. Kreinin.  Tuberculous pericarditis observed from the stage of effusion to pericardial calcification. , 1960, The American review of respiratory disease.

[40]  W. Evans,et al.  CONSTRICTIVE PERICARDITIS , 1952, British heart journal.

[41]  Soloff,et al.  [Tuberculous pericarditis]. , 1949, Arquivos brasileiros de medicina.

[42]  M. Mcnicol,et al.  Treatment of Tuberculosis , 1979, Journal of the Royal College of Physicians of London.

[43]  K. Sliwa,et al.  Mortality in patients treated for tuberculous pericarditis in sub-Saharan Africa. , 2008, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[44]  L. Cornillet,et al.  Likely tuberculous myocarditis mimicking an acute coronary syndrome. , 2008, Internal medicine.

[45]  H. Reuter,et al.  The management of tuberculous pericardial effusion: experience in 233 consecutive patients. , 2007, Cardiovascular journal of South Africa : official journal for Southern Africa Cardiac Society [and] South African Society of Cardiac Practitioners.

[46]  G. Freeman,et al.  Pericardial disease. , 2006, Circulation.

[47]  Y. Kambiré,et al.  [Pericarditis and HIV infection: retrospective study of 40 cases in Ouagadougou Burkina Faso] , 2001 .

[48]  J. Porter,et al.  Autopsy findings in HIV-1-infected adults in Kenya. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.